Related by context. All words. (Click for frequent words.) 72 RESEARCH SUMMARY 71 Gainsbourg Je t'Aime Moi 71 SINGING MEN AND 70 aligned Movement NAM 70 governmental Organisations NGOs 70 WOMEN ELKS #:#-#:# 69 Je T'Aime Moi 68 Broadcast Affiliated 68 Borrowed Reserves 66 Coding RNA 63 Cash Impairment Charge 63 Organisations NGO 62 Sufficient Funds 62 invasive Cervical Cancer 61 Precious Metals Base 61 Residential Retrofit 61 NATO Ally MNNA 60 Disclosure Agreements 60 NON AUDIT SERVICES 59 Stop Dusi 59 Government Organisations NGOs 59 resident Keralite 59 Institutional Bidders 59 Contact Thermometer 59 Qualified Deferred Compensation 58 System AVID MCXpress 58 Access NUMA 58 Federal SSP PKI 58 Financial Institutions Regulatory Authority 58 Process Plates 57 Organizations NGOs 57 Cash Goodwill Impairment 56 Sight NLOS 56 cumulative Redeemable 55 obese diabetic NOD 55 life insurer Millea 55 Agilent Full Bio 54 Non GAAP Adj 54 KODAK THERMAL DIRECT 53 recourse borrowings noncurrent 53 Interest Expenses 53 -megabases 52 Fixed Rate CMBS 52 volatile EEPROM 52 Compensation Expenses 51 ST Elevation Acute 51 Non 51 #,#,#,# #,#,#,# #,#,#,# #,#MATTHEW BARROWS 50 Paying Bidder 50 CNS systemic embolism 50 Assistance Program NAP 50 Transferrable 50 - - [060] 50 current liabilities# [002] 49 Heng Yi 49 Connected Transactions 48 De Minimis 48 Cytokinetics Announces 48 Operating Income Expense 48 [004] 48 Currency Fluctuations 47 Compen 47 Interest Expenses Salaries 47 Pays Dividend 47 Isocyanate 47 Legally Binding 47 -Richard Gitlen 47 Operating Expense Ratio 47 GBPm GBPm 47 Organisations NGOs 46 calcium phosphate binder 46 Mamani Bolivian 46 #,#,#,# #,#,#,# #,#,#,# 46 Fully Insured 46 -#.# -#.# [007] 46 Pro Rata 46 Set Asides 46 FAR #.#-# Evaluation 46 -#,# -#,# [005] 46 Taxable Income 46 Direc 46 Reconciling Items 46 Loan Chargeoffs 45 Compensation Expense 45 Grandfathered Plans 45 Disclosure Requirement 45 Than Temporary Impairment 45 Contrac 45 SILO LILO charges 45 PRE TAX OPERATING EARNINGS 45 Tax Exemptions 45 - EBITDA [003] 45 Deferral Plan 45 Invitee 45 Parent Entity 45 Wealth Inequality Data 45 brokered Private Placement 45 roster invitees 45 -#,# -# 45 BIOLASE Announces 45 Restatement Process 45 - Adjusted EBITDA [006] 45 #,#.# #,#.# [008] 45 Negatively Affect 45 Critically Important 44 DFARS #.#-# 44 Holdback 44 Density Functional Theory 44 Accts 44 liabilities #,#.# #,#.# [001] 44 Reclassified 44 - AdjusETON 44 =eReader.com 44 Fixed Remuneration 44 Segmental Analysis 44 FINANCIAL RISK MANAGEMENT 44 Gross Premiums Written 44 TOP Ships Announces 44 Cont. 44 WEIGHTED AVG 44 items NFIs 44 Non Interest Expense 44 - + - [017] 44 Capitalized Interest 44 Non Conforming 44 - INCOMAlberto Nagel 44 - STOCKHOLDERS EQUITY [002] 44 Divisions Subsidiaries 44 Cash Balances 44 Various Types 44 Expense Income 44 F3 ind 44 Unallocated expenses 44 #.# crore.Quarterly Results 44 ST EXPENSE Salaries 44 Tst 44 Patents Issued 44 Legal #.# 44 AQUARIUS PLATINUM LIMITED 44 -#.# -#.# -#.# [013] 44 Discontinued Ops 44 #,#,# #,#,# [001] 44 Single Detached 44 GBPm GBPm GBPm GBPm 44 Expense Benefit 44 Critically Ill Patients 44 #,# -Marhoefer 43 CDATA pre 43 Shareholders Equity Liabilities Deposits 43 AMEX aac 43 FFIs 43 Debt Obligations 43 + - [002] 43 Amorti 43 Income Expense 43 :5 43 Private Issuer #g# 43 Wholly Owned Subsidiaries 43 -#.# % [001] 43 GBP'# GBP'# 43 - - [087] 43 Cause Confusion 43 #,# #,# #,# #,# [002] 43 #.# #.# -noon Van Matre 43 Outsourcing Contracts 43 Tax Exempt Organizations 43 GBP GBP 43 CNinsure Announces 43 Non Recurring 43 Data Indicate 43 Written Premiums 43 Grantor Trust 43 Crop Disaster Assistance 43 Derivative Transactions 43 Anworth Announces 43 Improving Efficiency 43 Contribution Margin 43 -#,#.# [001] 43 -#.# -#.# [011] 43 Stmt 43 - - [002] 43 § #.#-# [004] 43 -# -#,# 43 Total nonaccrual loans 43 Wholly Owned 43 - Adjusted [029] 43 -Bairagi 43 #,#,#,#,#,#,# [001] 43 Subtype 43 Capital Formation GFCF 43 Product Lines 43 #.# #.# [005] 43 AND SHAREHOLDERS EQUITY Deposits 42 Dividend Rate 42 - Adjusted EBITDA [004] 42 Net Tangible Assets 42 GBPm GBPm GBPm 42 - Operating [008] 42 GBPm 42 -#,# -#,# [011] 42 Ordinary Dividends 42 - Adjusted EBcredible degrees Winneg 42 -exhaust tailpipe 42 Parking Fines 42 = Operaanalytic geometry 42 NO EXP 42 Liability Coverage 42 Reclassify 42 Actively Seeking 42 Dividend Payment 42 -#.# -#.# -#.# -#.# [008] 42 Warrants Exercised 42 Infl 42 Payee 42 Convertible Subordinated 42 Clean MVR 42 Code # 42 -#,# -#,# [010] 42 ANALYSIS OF NON 42 Redeemable Preference Shares 42 Pension Schemes 42 Applic 42 - Adjusted [028] 42 Varies Widely 42 Struct 42 Valid Driver License 42 FAR #.#-# [001] 42 [017] 42 -Carl Kieke 42 Ownership Structure 42 Partly Paid 42 Investig 42 Comprises 42 Downpayment Assistance 42 consoli dated 42 Noncash 42 #,#,#,# [002] 42 income# [001] 42 .1 .1 42 Non Regulated 42 - - [008] 42 Purchased intangibles 42 #,# #,# [003] 42 Sleep Duration 42 - Adjusted EBITDA [003] 42 Disclosure Requirements 42 Secretory 42 Support '1 42 Competitive Bids 42 .1 .3 42 Stapling applies 42 - - [050] 42 Other Income Deductions 42 Adviser Exemption 42 Susceptibility Testing 42 CONTINGENCIES 42 + -Thimarafushi 41 Continuous Disclosure 41 -IPOBoutique.com 41 Import Duty 41 - - Total [059] 41 Immediate Effect 41 -#.# -#.# -#.# [010] 41 Eligibility Requirements 41 -FreeAgent Pro 41 Payment Amount 41 Renewable Natural Resources 41 Shellfish Harvesting 41 Waiting Periods 41 #,#,#,# [010] 41 Creditworthiness 41 Smooth Muscle 41 NON INTEREST EXPENSE Salaries 41 Sales Tax Deduction 41 Rfdg Bonds 41 Premiums Earned 41 - - [124] 41 Preferred Stock Dividend 41 Protein Synthesis 41 Authorisations 41 Clinical Outcome 41 Roaming Rates 41 EXPENSE Salaries 41 Companies Profiled 41 Imputation 41 Related Parties 41 -#.# -#.# -#.# -#.# [001] 41 - Adjusted [033] 41 preferably conversant 41 TELEPERFORMANCE 41 R'# R'# 41 Appendix 4D item 41 TRUST PLC 41 Roaming Charges 41 - Adjusted [016] 41 Market Stabilizes 41 Hematological Cancers 41 - Operating [019] 41 - - [126] 41 - - TotalYourLink 41 -#.# pp [002] 41 Knee Replacements 41 Medicure Announces 41 CORPORATE INFORMATION 41 Disord 41 #-#.# [016] 41 - Total noninterest [001] 41 CONTINGENCIES AND 41 Addback 41 - Operating [014] 41 Currency Basket 41 Yield Spreads 41 TIC Flows 41 T Lymphocyte 41 -#,# #,# [002] 41 Adverse Event 41 - Expenses [007] 41 Supplemental Figure 41 Eligibility Verification 41 Proxy Votes 41 Interest Rates Remain 41 - - [019] 40 Export Credits 40 Incl. 40 Liquid Hydrocarbons 40 -#,# -#,# -#,# [004] 40 LBBB + 40 Final Standings 40 Drug Reactions 40 Compl 40 Excludes depreciation 40 - -profitabilty 40 XPEL Announces 40 -NEFC Bogan 40 Rates Remain 40 PRESS RELEASE Fitch Downgrades 40 For Against Abstain 40 Subscriber Acquisition 40 Beneficially Owned 40 Transl 40 Filing Requirements 40 Latent Demand 40 Learning Experiences 40 Bnds 40 GMO soybeans 40 Unch 40 Goodwill impairment - [002] 40 NON 40 -#,#,# -#,#,# [001] 40 #,#,# #,#,# #,#,# -ATLANTA Jeff Francoeur 40 -Queen Elizabeth Stakes Eng 40 Dividends Payable 40 Denominated 40 #,#.# #,#.# #,#.# [005] 40 -#,# -# -#,# 40 Issues Relating 40 crore.Quarterly Results 40 Regular Monthly Distributions 40 #,#.#,#.# 40 -#,# -#,# [002] 40 ICANN Approves 40 - TOTAL [022] 40 OBLIGATIONS UNDER CAPITAL LEASES 40 #,# -oxidative enzymes 40 weighted avg 40 Peginterferon Alfa 2a 40 Telecoms Operators 40 -agriculture Renson Gasela 40 GBP'# 40 Dividend Distributions 40 Spin Offs 40 = Operating [002] 40 % EBITDARM margin 40 FAR #.#-# [003] 40 Interest Bearing 40 - -Mike Butia 40 Weight Loss Diets 40 Says Rafidah 40 Organizational Structure 40 SECOND GUIDE TO 40 Direct Indirect 40 F4 ind 40 ACCUMULATED OTHER COMPREHENSIVE LOSS 40 - - [007] 40 SUPPLEMENTAL CASH FLOW INFORMATION 40 - Non GAAP [025] 40 Union NASU 40 Cluster Headaches 40 Revises Outlooks 40 Amount Amount 40 Depr 40 Reacquisition 40 Reporting Requirements 40 Contract Modifications 40 FOIA Requests 40 - - [041] 40 IFS Ratings 40 Pounds Per 40 Deductibility 40 Bad Debts 40 Contrast Enhancement 40 -#,# -#,# [009] 40 MedMira Announces 40 - -Clines Corners 40 Permissible 40 non 40 Callable 40 - Operating [028] 40 #.#B [003] 40 Mitigated 40 Lending Rates 40 Entitlement Programs 40 Abbreviation 40 - - Total [002] 40 - Adjusted [018] 40 Foreseeable 40 Regulatory Requirements 40 GBP'# GBP'# GBP'# 40 #,# #,# #,# [001] 40 Safeguarded 40 #,#.# [025] 40 Obligor 40 Relinquishment 39 Regularization 39 Systemically Important 39 EU AIFM 39 #.#-# [005] 39 #-#/# #-#/# [006] 39 Stent Placement 39 Disposable Income 39 - - Net Loss Attributable 39 Term Loans 39 Financing Arrangement 39 #,#,#,# [018] 39 -ABGL 39 -#,# -#,# [012] 39 Highly Speculative 39 Metallic Screen 39 #,#,# #,#,# -Provides Status 39 Chartis Introduces 39 - - [062] 39 #,# =Fiderion 39 -Ionna 39 -hooker Marius Tincu 39 Senior Unsecured Debt 39 Earnings Release Dates 39 Tradenames 39 Grow Faster 39 Shareholding 39 Practical Considerations 39 Preferential Basis 39 - TOTAL [027] 39 Teaching Positions 39 Tradable 39 - - [005] 39 DAC offsets 39 #,#.# #,#.# - [001] 39 -1 -1 39 Financial Institutions Act BOFIA 39 #,#,#,# #,#,#,# [002] 39 Watch Neg 39 Intangibles amortization 39 Funds Announce 39 - Expenses [008] 39 Prison Sentences 39 Units RSUs 39 Emerg 39 Noncore 39 - Adjusted EBIJoaquim Rafael 39 Mtge 39 Solar Water Heaters 39 Jointly Owned 39 Pension Obligations 39 Pension Plans 39 Indebtedness 39 Equity Fixed Income 39 Hsg 39 Default Risk 39 Severability 39 INR#.#m [001] 39 - - [071] 39 Antiretroviral Drug 39 -Athletic Bilbao Telmo Zarra 39 Cell Viability 39 Energy Sources MNES 39 - Adjusted [034] 39 Parking Spots 39 #,#,#,# [016] 39 -#,# -#,# [004] 39 ESRB Rating 39 Be Avoided 39 - + [009] 39 Reprod 39 Annex Notification 39 SOHC Automatic 39 Funds Declare Monthly Dividends 39 #,# #,# #,# [008] 39 TFT LCD Panel 39 PDL BioPharma Announces 39 Excludes amortization 39 - Expenses [009] 39 G roup 39 Default Rate 39 Termination Fees 39 #MM Sr 39 Swap Dealers 39 InStorage REIT Announces 39 Cents Cents Basic 39 Potable 39 Caa 39 - REVENUES [007] 39 Isomer 39 -Emily Kerstetter 39 Oil MBbl 39 NAICS # [001] 39 F.# [002] 39 Bd OKs 39 Arbitration Agreements 39 Incentive Programs 39 CONTINUING CONNECTED TRANSACTIONS 39 -#.# -#.# -#.# [003] 39 LIABILITIES AND EQUITY Current 39 Special Purpose Entity 39 - - [015] 39 + - [010] 39 Redemption Amount 39 -Batho Pele 39 Exh 39 Allottees 39 Deprec iation 39 - - [086] 39 INR#.#m [002] 39 Perceived Value 39 Operational Capability 39 Nonimmigrant 39 Newly Diagnosed 39 Alcohol Intake 39 EURm 39 =America Airline Satisfaction 39 nhs dispensing 39 Smartphone Platforms 39 Commitments Stockholders equity 39 Chart Presentation 39 Antidepressant Treatment 39 Convertible Preference Shares 39 Inj 39 #,# -Abdullah Hamoud 39 - Non GAAPalanquero base 38 Dietary Intake 38 Penetration Rate 38 #,#,#,# [009] 38 Secured Creditors 38 Currency IDRs 38 Saleable 38 OTHER MATTERS 38 Minimum Subscription 38 Polymorphisms 38 - TOTAL [001] 38 expense# [002] 38 Growth Trajectory 38 Depreciations 38 - - [058] 38 Tax Equivalent Yield 38 CASM excluding 38 - -Prevelle 38 Defined Benefit Plans 38 - Revenues [003] 38 Entity 38 Advanced Pancreatic Cancer 38 Convertible Warrants 38 Deferred Credits 38 GBP'# GBP'# GBP'# GBP'# 38 A2 A3 38 Input Module 38 - INVESTING ACTIVITIES [004] 38 expenses# [002] 38 -4 -4 38 CDO #-# 38 Director PDMR 38 Structural Changes 38 Study Recommends 38 Orally Active 38 GROUP LIMITED ABN 38 - - [045] 38 LEAPS construct 38 #,#.# [013] 38 Fungal Infections 38 Evaporates 38 Proxy Disclosure 38 Ratios Loss 38 Excess Liquidity 38 Study Analyzes 38 - -southwest@lillienews.com 38 #-#/# #-#/# #-#/# [004] 38 Convertible Preference 38 Nil Nil Nil 38 KZT #.#bn [001] 38 Notional Amount 38 Tumor Cell 38 Cut Greenhouse Gases 38 Outstanding Indebtedness 38 Recoupment 38 - - [077] 38 Staffing Levels 38 Terrorist Groups 38 mr holland brown 38 Noncash investing 38 Ticker Symbols 38 Security Bypass Vulnerability 38 Corporate Governance Policies 38 Preclude 38 Obtains Financing 38 Tax Burdens 38 Constitutes 38 Mistakes Made 38 Westpac SFIs 38 #,# =vahn 38 Inducement 38 Bilgena Read Terms 38 Portend 38 Imputed 38 Perfor 38 Debt Issuance 38 CURRENT ASSETS Inventories 38 - Adjusted [015] 38 Insureds 38 Streptococcal 38 - - [036] 38 Tangible Equity 38 - RevenuesChhobi 38 Material Facts 38 - - Income [035] 38 - Adjusted [003] 38 NON CONTROLLING INTEREST 38 -#.# -#.# [001] 38 #,#.# % [002] 38 - Non GHanno Coetzee 38 Gaited 38 Cbl 38 Nuclear Warheads 38 rated Baa 38 ASX Listing 38 - - Total [003] 38 Drug Regimen 38 Qualification Requirements 38 Identifiers 38 Platelet Aggregation 38 Goods Vehicles 38 Roth IRA Conversions 38 Lawfully 38 WAC #-#-# 38 - - [130] 38 TOTAL OTHER INCOME 38 PFICs 38 #,#,# [005] 38 -9st 4lbs 38 Shareholdings 38 - - [090] 38 Insulin Glargine 38 Legal Considerations 38 #,# =Bill Duemling 38 - Unaudited [001] 38 Health Serv Res 38 = Non GAAP [005] 38 Viable Alternative 38 -#.# -#.# [005] 38 -NM Sequeira 38 # - -Cult Editor 38 Drinking Water Treatment 38 F Ascending 38 DIAGNOS Announces 38 #,# -Jon Cisna 38 INCOME LOSS BEFORE PROVISION 38 - Revenues [006] 38 Vacancy Rates 38 Innovene operations 38 Not Applicable 38 Denominator 38 Capitalized lease 38 EUR1 Billion 38 - Total noninterest expense 38 - - Non GAAP [002] 38 AND INCOME TAXES 38 TOTAL EQUITY 38 SEGMENTAL INFORMATION 38 - Revenues [002] 38 -#,# -#,# -#,# [001] 38 Plus Ribavirin 38 Relat 38 Debt Restructure 38 - - [121] 38 - - [106] 38 Indemnities 38 -#.# -#.# -#.# [012] 38 Protease Inhibitor 38 Average Balances Assets 38 STRUCTURED 38 Hobby Pony 38 Sees Slight 38 Req 37 - - Total [042] 37 metallic minerals 37 Publicly Traded Companies 37 Exercise Notices 37 Indexed Annuities 37 Woody Biomass 37 Hedge ineffectiveness 37 -#.# -#.# -#.# [002] 37 Phytosterol 37 Elaboration 37 RESPONSIBILITY FOR NON DELIVERY 37 Double Taxation Agreements 37 #,#,# #,# -Lavalas supporters 37 Synthetic CDO 37 Optionholder 37 Genuine Occupational 37 Tendered 37 Deaths Prompt 37 Predict Response 37 Sharing Agreements 37 -#.# -#.# -#.# [005] 37 Unrealised 37 - Adjusted [012] 37 Loan Receivables 37 Antibiotic Therapy 37 Competences 37 Fusion Proteins 37 #,#,# #,#,# - [013] 37 #,#,#,#,# [004] 37 Diversified Portfolio 37 .W. McNichols 37 Personality Disorder 37 NRCHA Snaffle Bit Futurity 37 Currency Hedging 37 Diabetic Patients 37 Credit Card ABS 37 Shareholder Applicants 37 - - Total [037] 37 Current liabilities Borrowings 37 - Jim Clack 37 Extendible 37 Accounts receivable #,#,# #,#,# [002] 37 Guaranteed Minimum 37 .PHOTOs 37 Prices Stabilize 37 Add subtract 37 Moral Dilemma 37 Tradeable 37 - - Non arachnophobes 37 Asthma Inhaler 37 Variable remuneration 37 Profi t 37 Native CDFIs 37 - Stockholders equityKarsh Hagan 37 SatBroadcasting 37 -DEAD BODY 37 - Adjusted [006] 37 Follicular Lymphoma 37 R eport 37 Opportunities Exist 37 Coal Liquefaction 37 Ceded 37 Unrecoverable 37 Paid Ordinary 37 Iron Overload 37 Mold Remediation 37 -Mullaloo 37 Traceable 37 Mandatory Conversion 37 Non Negotiable 37 -#.# -#.# -#.# [009] 37 - - Total [053] 37 Society VICTIM 37 Religious Belief 37 Flagstone Re Announces 37 #a [004] 37 - - Total [033] 37 UPC # Manufacturer 37 Mgd 37 EQUITY RESIDENTIAL 37 Acres Addition 37 Randomized Placebo Controlled Trial 37 Industr 37 Undrawn 37 Underpinnings 37 #,#,# - [003] 37 Common Pitfalls 37 Pract 37 DWS RREEF 37 Maximize Value 37 Euronext Paris Compartment 37 Character Customization 37 Debt Obligation 37 Acute Pancreatitis 37 Men Recurve 37 - -Bredbury 37 Molecular Structure 37 NRCHA Stakes 37 XS# [003] 37 CanTex Energy Corp. 37 Sell Offs 37 -Wat Phra Kaew 37 -Candleford 37 Interest Rate Derivatives 37 Pig Farming 37 Panic Disorder 37 -Tilak Marg 37 Cytoplasmic 37 Leasehold inducements 37 #,# #,# #,# [011] 37 - OperatingAlcoholics Anonymous nonsmoking 37 Substantial Shareholder 37 No Minimums 37 Expiries 37 - - [066] 37 Placement Agents 37 Sufficient Evidence 37 #,#,# #,#,# - [007] 37 Inhaled Corticosteroids 37 SHAREHOLDERS FUNDS 37 Arms Length 37 -# -# -#,# 37 Milestone Achieved 37 Certifi cate 37 Antiepileptic Drug 37 - + [011] 37 shares viii ix 37 Restrains 37 INTUIT INC. 37 - INCOME LOEducation HMIe 37 - -Schaake 37 - Adjusted [009] 37 Snow Plowing 37 Reductase 37 Svc 37 Biofuel Crops 37 Purported Class 37 Fd 37 OTHER INCOME EXPENSE NET 37 =Verwaltungsgesellschaft mbH 37 OTHER INCOME 37 - - [059] 37 Sustainable Livelihood 37 Intermediation 37 pacers #m 37 Nonstandard 37 Currency translation adjustment 37 Drillships 37 Antiviral Drug 37 Compliance Requirements 37 - Operating [022] 37 Realizations 37 - Non GAAP [004] 37 - - [043] 37 Deferred Income Tax 37 CHMP Opinion 37 Funds Declare Quarterly 37 Stockholders Equity #,#.# #,#.# 37 #.# [042] 37 Accumulation Plan 37 - - Non GAAP [001] 37 Variation Variation 37 - Operating Expenses [005] 37 Adenocarcinoma 37 Fiscal Deficit 37 Tool Enables 37 IFS Rating 37 RATE ANALYSIS Assets 36 Hindrance 36 Preventing Disease 36 - Operating [004] 36 Move Towards 36 Financially Distressed 36 ENTITY 36 = Net [019] 36 Port Auth 36 Shareowner 36 Pesticide Applicator 36 Assigns Outlooks 36 - ToTrain Derails 36 nb1 36 Regulatory Approvals 36 #-# #-# [006] 36 Genetic Defect 36 Syndicated Facility 36 -#,#.# -#,#.# 36 term IDR F2 36 - TOTAL [003] 36 FUTURE INCOME TAXES 36 - -Brigadier General Erv Lessel 36 Evidence Suggests 36 #,# -appartment 36 Vermögensverwaltung GmbH 36 Accountancy Firm 36 Unserved 36 Vitality Re 36 Bearish Trend 36 - Operating [006] 36 Borrowing Fee 36 RELATED PARTY TRANSACTIONS 36 Fixed Rate Bonds 36 Dwelling Units 36 Double Blind Randomized 36 - Gross [015] 36 - Stave Lake 36 -reliever Eddie Kunz 36 Glb 36 Telomere Length 36 Uninsured Underinsured Motorist 36 [009] 36 Ratings Lowered 36 DIRECTORS REPORT REMUNERATION REPORT 36 Fixed Rate 36 #C# [002] 36 Showed Significant 36 ABN AMRO MINIs 36 #,#,#,#,#,# [001] 36 PT Ctfs 36 Assigns LS Ratings 36 -cushy gig 36 Tumor Suppressor Gene 36 Calorie Diet 36 LIMITED DIRECTORS REPORT 36 Width m 36 amorti zation 36 Factorial 36 - Total revenues 36 Affect Ratings 36 Regulatory Frameworks 36 - - [001] 36 Potentially Hazardous 36 #J [004] 36 Prices Plummet 36 - - [038] 36 Rolled Glass 36 - - Total [032] 36 Statutory Liquidity 36 Redeemable preference 36 B. Boodramsingh 36 DFARS 36 Related Injuries 36 Microfluidic Devices 36 Depreciation -#.# -#.# 36 - - Totcheering lustily 36 Invasive Pneumococcal Disease 36 ORD GBP 36 INVESTMENTS LIMITED 36 BANK CAPITAL 36 -2 -2 36 - Non GAAP [017] 36 Secured Debt 36 - Adjusted [019] 36 - Loss [021] 36 Mgrs 36 Prognostic Factors 36 Cellular Immunotherapy 36 Quarter Ended #/#/# #/#/# [001] 36 Novel Therapeutic 36 -Murabayashi 36 Profit Loss 36 operations# 36 LPT Agreement 36 Electronic Passports 36 Hydropower Projects 36 Fatty Acid 36 Hedging Contracts 36 Rollover Amount 36 - - Net [047] 36 Acquisition Proposal 36 Unallocated corporate 36 Precondition 36 pfd 36 #,#.# #,#.# [004] 36 Concessional 36 - - [016] 36 Cognitive Dysfunction 36 #,# -Reid Brignac homered 36 iSHARES 36 -#.# -#.# -#.# [006] 36 - - Operating [001] 36 #,#,# = [009] 36 Artery Disease 36 Equity Funds Declare 36 Equivalence 36 #Q# #Q# Var 36 .execute arbitrary SQL 36 Total Liabilities #,#,# #,#,# [002] 36 Excess Liability 36 Anti Tumor 36 Consequential 36 Ayoon Wa Azan 36 Wkly 36 Fundamentally Flawed 36 - -watt amp 36 - - [061] 36 Subparagraph 36 -Gail Lissner vice 36 Malpractice Claims 36 Male Pattern Baldness